Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma

J Thorac Oncol. 2018 Mar;13(3):e36-e39. doi: 10.1016/j.jtho.2017.10.022.

¹ Department of Oncology, National Taiwan University Hospital, Taipei, Republic of China.
² Department of Oncology, National Taiwan University Hospital, Taipei, Republic of China; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Republic of China; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Republic of China. Electronic address: jhecyuanguo@ntu.edu.tw.
³ Department of Pathology, National Taiwan University Hospital, Taipei, Republic of China; Department of Pathology, National Taiwan University College of Medicine, Taipei, Republic of China.
⁴ Department of Oncology, National Taiwan University Hospital, Taipei, Republic of China; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Republic of China.

No abstract available

Publication types